Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025)

Benitec Biopharma has reported Amortizatization of Intangibles for 7 years, with the latest figure at $106000.0 in Q4 2025.

• Quarterly Amortizatization of Intangibles rose 260.61% year-over-year to $106000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $541000.0 (up 316.15% YoY) and the FY2025 annual result came in at $330000.0, up 28.91% from the prior year.
• Amortizatization of Intangibles improved to $106000.0 in Q4 2025 per BNTC's latest filing, from $105000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $330000.0 in Q2 2025 and troughed at -$66000.0 in Q4 2024.
• A 5-year average of $71842.1 and a median of $61000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles plunged 204.76% in 2024, then surged 407.69% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $58000.0 in 2021, then climbed by 5.17% to $61000.0 in 2022, then advanced by 3.28% to $63000.0 in 2023, then slumped by 204.76% to -$66000.0 in 2024, then soared by 260.61% to $106000.0 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $106000.0, $105000.0, and $330000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.